Status:
RECRUITING
ST250 as a Therapeutic Option for Head & Neck Reconstruction
Lead Sponsor:
Alaa Emara
Conditions:
Tonsillitis
Eligibility:
All Genders
18+ years
Phase:
PHASE1
PHASE2
Brief Summary
To assess the use of SupraThel 250 for mucosal reconstruction in the Head \& Neck region. The membrane will be applied after tonsillectomy procedures and compared to bare wounds' healing
Detailed Description
After tonsillectomy procedures, the wound is usually left bare to heal. This causes severe pain postoperatively and postoperative hemorrhage. SupraTHEL 250 is a synthetic biodegradable PLA membrane wh...
Eligibility Criteria
Inclusion
- recurrent episodes of tonsillar infection
Exclusion
- children
- pregnant/ breastfeeding women
- patients undergoing chemo / radiotherapy
Key Trial Info
Start Date :
April 30 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2026
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06543823
Start Date
April 30 2025
End Date
February 1 2026
Last Update
May 18 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
MarienHospital
Stuttgart, Baden-Wurttemberg, Germany, 71638